About Prima Mente
CFDX aims to apply the liquid biopsy techniques used in early cancer detection to neurodegenerative diseases, enabling diagnosis decades before symptoms appear.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Seed
Global Headquarters
United Kingdom
Tracked Since
Sep 28, 2026
Web & Domain Identity
Official Website
primamente.com
Domain Registered Date
Jan 28, 2025
Social & Network Presence
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Seed announced
- Milestone
X account created (@PrimaMente)
1.1K followers
- Milestone
Website domain registered
primamente.com
Investors & Backers
Antler
Funding History
Seed
· Apr 16, 2026
Undisclosed
Venture Round
· Undisclosed
Undisclosed Source
Founders & Leadership
Jonathan Wan
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026